1h Free Analyst Time
Global Respiratory Syncytial Virus Diagnostics Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The respiratory syncytial virus diagnostics market is poised to grow by $ 585.17 million during 2020-2024 progressing at a CAGR of 10% during the forecast period. The report on the respiratory syncytial virus diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in product launches, government and non-profit organization initiatives to diagnose RSV, and growing number of M&A. In addition, increase in product launches is anticipated to boost the growth of the market as well.
The respiratory syncytial virus diagnostics market analysis includes product segment and geographic landscapes.
The respiratory syncytial virus diagnostics market is segmented as below:
By Product
- Consumables
- Systems
By Geographic Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the technological advancements as one of the prime reasons driving the respiratory syncytial virus diagnostics market growth during the next few years. Also, growing number of OEMs, and supportive initiatives by regulatory bodies will lead to sizable demand in the market.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The respiratory syncytial virus diagnostics market covers the following areas:
- Respiratory syncytial virus diagnostics market sizing
- Respiratory syncytial virus diagnostics market forecast
- Respiratory syncytial virus diagnostics market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading respiratory syncytial virus diagnostics market vendors that include Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Quidel Corp., Seegene Inc., and Thermo Fisher Scientific Inc. Also, the respiratory syncytial virus diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
This market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global respiratory syncytial virus diagnostics market: Abbott Laboratories, Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Quidel Corp., Seegene Inc., and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the technological advancements."
According to the report, one of the major drivers for this market is the increase in product launches.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton
- Dickinson and Co.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Quidel Corp.
- Seegene Inc.
- Thermo Fisher Scientific Inc.
